Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists In Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials

Majed S. Al Yami, PharmD, BCPS, ASH-CHC, Osamah M. Alfayez, PharmD, CDE, Razan Alsheikh, PharmD, BCPS,  "Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists In Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials”   -Heart, Lung and Circulation (2018) xx, 1–9 |https://doi.org/10.1016/j.hlc.2018.03.018

 

Please click here to see the article.

Developed by:  EduTech / COP-ITS 2017